Literature DB >> 16649727

Depression and thyroid axis function in coronary artery disease: impact of cardiac impairment and gender.

Robertas Bunevicius1, Giedrius Varoneckas, Arthur J Prange, Alan L Hinderliter, Vilte Gintauskiene, Susan S Girdler.   

Abstract

BACKGROUND: Increased rates of depression are reported in coronary artery disease (CAD). In heart disease, depression increases disability, reduces quality of life, and increases mortality. HYPOTHESIS: The study was undertaken to examine the relationship between depression and thyroid axis function in patients with CAD.
METHODS: In all, 73 patients with CAD, consecutively admitted to a cardiac rehabilitation hospital, were assessed for depression using the Hospital Anxiety and Depression scale (HADS). Blood was drawn for assessment of thyroid axis hormones and the N-amino terminal fragment of the pro-B-type natriuretic peptide (NT-pro BNP).
RESULTS: The patients with CAD with depressive symptoms had a higher prevalence of cardiac failure (p = 0.04), higher NT-pro BNP concentrations (p = 0.02), and lower free triiodothyronine (T3) concentrations (p = 0.04) than patients with CAD but without depressive symptoms. They also showed a strong trend (p = 0.058) toward a higher incidence of the low T3 syndrome. Higher NT-pro BNP concentrations were related to lower total T3 concentrations (r = -0.294, p = 0.011) and to higher reverse T3 concentrations (r = 0.353, p = 0.002). In men, higher scores of depression were related to lower total T3 concentration (r = -0.289, p = 0.034) and to higher NT-pro BNP concentration (r = 0.380, p = 0.005).
CONCLUSION: These findings suggest that symptoms of depression in patients with CAD are associated with changes in thyroid axis function and with cardiac impairment, especially in men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16649727      PMCID: PMC6654096          DOI: 10.1002/clc.4960290409

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  26 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Gender and psychosomatic aspects of ischemic heart disease.

Authors:  S E Abbey; D E Stewart
Journal:  J Psychosom Res       Date:  2000 Apr-May       Impact factor: 3.006

3.  Early manifestations of "sick euthyroid" syndrome in patients with compensated chronic heart failure.

Authors:  H Shanoudy; A Soliman; S Moe; D Hadian; J D Veldhuis; A Iranmanesh; D C Russell
Journal:  J Card Fail       Date:  2001-06       Impact factor: 5.712

4.  B-type natriuretic peptide -- a window to the heart.

Authors:  Kenneth L Baughman
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

5.  Predictors of quality of life 6 months and 1 year after acute myocardial infarction.

Authors:  C A Beck; L Joseph; P Bélisle; L Pilote
Journal:  Am Heart J       Date:  2001-08       Impact factor: 4.749

6.  Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction.

Authors:  L Friberg; V Drvota; A H Bjelak; G Eggertsen; S Ahnve
Journal:  Am J Med       Date:  2001-12-15       Impact factor: 4.965

7.  Determinants of disability in older coronary patients.

Authors:  Philip A Ades; Patrick D Savage; Marc D Tischler; Eric T Poehlman; Justine Dee; Joelyn Niggel
Journal:  Am Heart J       Date:  2002-01       Impact factor: 4.749

Review 8.  Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state.

Authors:  Deborah D Ascheim; Katarzyna Hryniewicz
Journal:  Thyroid       Date:  2002-06       Impact factor: 6.568

Review 9.  Thyroid hormone and cardiac surgery.

Authors:  John D Klemperer
Journal:  Thyroid       Date:  2002-06       Impact factor: 6.568

10.  Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease.

Authors:  Giorgio Iervasi; Alessandro Pingitore; Patrizia Landi; Mauro Raciti; Andrea Ripoli; Maria Scarlattini; Antonio L'Abbate; Luigi Donato
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

View more
  7 in total

1.  Early and Short-term Triiodothyronine Supplementation Prevents Adverse Postischemic Cardiac Remodeling: Role of Transforming Growth Factor-β1 and Antifibrotic miRNA Signaling.

Authors:  Giuseppina Nicolini; Francesca Forini; Claudia Kusmic; Letizia Pitto; Laura Mariani; Giorgio Iervasi
Journal:  Mol Med       Date:  2015-11-23       Impact factor: 6.354

2.  Do Different Depression Phenotypes Have Different Risks for Recurrent Coronary Heart Disease?

Authors:  Jonathan A Shaffer; William Whang; Daichi Shimbo; Matthew Burg; Joseph E Schwartz; Karina W Davidson
Journal:  Health Psychol Rev       Date:  2012

3.  Cardiac Risk Markers and Response to Depression Treatment in Patients With Coronary Heart Disease.

Authors:  Robert M Carney; Kenneth E Freedland; Brian Steinmeyer; Eugene H Rubin; Douglas L Mann; Michael W Rich
Journal:  Psychosom Med       Date:  2016-01       Impact factor: 4.312

4.  Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes.

Authors:  Insa Feinkohl; Naveed Sattar; Paul Welsh; Rebecca M Reynolds; Ian J Deary; Mark W J Strachan; Jackie F Price
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

5.  Comorbidities and Consequences in Hospitalized Heart Failure Patients with Depression.

Authors:  Rikinkumar S Patel; Shristi Shrestha; Hina Saeed; Sanjeetha Raveendranathan; Ehinor E Isidahome; Virendrasinh Ravat; Mary O Fakorede; Viralkumar Patel
Journal:  Cureus       Date:  2018-08-23

6.  Low fT3 is associated with diminished health-related quality of life in patients with acute coronary syndrome treated with drug-eluting stent: a longitudinal observational study.

Authors:  Chao Xue; Ling Bian; Yu Shui Xie; Zhao Fang Yin; Zuo Jun Xu; Qi Zhi Chen; Hui Li Zhang; Yu Qi Fan; Run Du; Chang Qian Wang
Journal:  Oncotarget       Date:  2017-10-10

7.  BNP as a New Biomarker of Cardiac Thyroid Hormone Function.

Authors:  Kaihao Wang; Kaie Ojamaa; Abigail Samuels; Nimra Gilani; Kuo Zhang; Shimin An; Youhua Zhang; Yi-Da Tang; Bardia Askari; Anthony Martin Gerdes
Journal:  Front Physiol       Date:  2020-07-09       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.